Talat H. Malik
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
A novel fusion protein reduces kidney complement in experimental C3 glomerulopathy.
Journal: Clinical and experimental immunology
Published: December 05, 2025
Temporal multi-omics analysis of COVID-19 in end-stage kidney disease.
Journal: Cell genomics
Published: June 28, 2024
A novel mutation in EROS (CYBC1) causes chronic granulomatous disease.
Journal: Clinical immunology (Orlando, Fla.)
Published: April 17, 2023
Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy.
Journal: Journal of the American Society of Nephrology : JASN
Published: October 08, 2021
Homodimeric Minimal Factor H: In Vivo Tracking and Extended Dosing Studies in Factor H Deficient Mice.
Journal: Frontiers in immunology
Published: August 03, 2021
Adeno-Associated Virus Vector Gene Delivery Elevates Factor I Levels and Downregulates the Complement Alternative Pathway In Vivo.
Journal: Human gene therapy
Published: July 09, 2021
Severe COVID-19 is associated with endothelial activation and abnormal glycosylation of von Willebrand factor in patients undergoing hemodialysis.
Journal: Research and practice in thrombosis and haemostasis
Published: May 08, 2021
Gain-of-function factor H-related 5 protein impairs glomerular complement regulation resulting in kidney damage.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 23, 2021
Murine Factor H Co-Produced in Yeast With Protein Disulfide Isomerase Ameliorated C3 Dysregulation in Factor H-Deficient Mice.
Journal: Frontiers in immunology
Published: March 15, 2021
Defining the Glycosaminoglycan Interactions of Complement Factor H-Related Protein 5.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 22, 2020
Last Updated: 09/26/2026